Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Notes Payables: 2021-2024

Historic Notes Payables for Core Scientific (CORZ) over the last 4 years, with Dec 2024 value amounting to $16.3 million.

  • Core Scientific's Notes Payables fell 30.51% to $16.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $16.2 million, marking a year-over-year decrease of 30.51%. This contributed to the annual value of $16.3 million for FY2024, which is 86.90% down from last year.
  • Per Core Scientific's latest filing, its Notes Payables stood at $16.3 million for FY2024, which was down 86.90% from $124.4 million recorded in FY2023.
  • Over the past 5 years, Core Scientific's Notes Payables peaked at $124.4 million during FY2023, and registered a low of $16.3 million during FY2024.
  • Its 3-year average for Notes Payables is $59.0 million, with a median of $36.2 million in 2022.
  • Its Notes Payables has fluctuated over the past 5 years, first surged by 243.13% in 2023, then tumbled by 86.90% in 2024.
  • Over the past 4 years, Core Scientific's Notes Payables (Yearly) stood at $76.0 million in 2021, then slumped by 52.31% to $36.2 million in 2022, then skyrocketed by 243.13% to $124.4 million in 2023, then slumped by 86.90% to $16.3 million in 2024.